Lydia Eleanor Wiedel Pace, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 46 | 2022 | 19800 | 3.470 |
Why?
|
Early Detection of Cancer | 20 | 2023 | 2865 | 3.430 |
Why?
|
Mammography | 19 | 2022 | 2442 | 3.300 |
Why?
|
Contraception | 9 | 2022 | 311 | 2.360 |
Why?
|
Contraceptive Agents, Female | 5 | 2019 | 120 | 1.990 |
Why?
|
Intrauterine Devices | 4 | 2019 | 111 | 1.790 |
Why?
|
Abortion, Legal | 4 | 2022 | 93 | 1.750 |
Why?
|
Rwanda | 13 | 2022 | 746 | 1.640 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2021 | 1161 | 1.540 |
Why?
|
Insurance Coverage | 10 | 2022 | 1847 | 1.200 |
Why?
|
Cost Sharing | 5 | 2019 | 400 | 1.130 |
Why?
|
Family Planning Services | 4 | 2021 | 235 | 1.100 |
Why?
|
Medicaid | 10 | 2022 | 2613 | 1.070 |
Why?
|
General Practitioners | 2 | 2022 | 101 | 1.000 |
Why?
|
Women's Health Services | 2 | 2017 | 93 | 0.970 |
Why?
|
Contraceptive Agents | 3 | 2022 | 122 | 0.900 |
Why?
|
Breast | 7 | 2022 | 1782 | 0.820 |
Why?
|
Women's Health | 6 | 2020 | 1898 | 0.740 |
Why?
|
Eligibility Determination | 1 | 2022 | 382 | 0.690 |
Why?
|
Abortion, Induced | 1 | 2022 | 364 | 0.680 |
Why?
|
Deductibles and Coinsurance | 1 | 2021 | 345 | 0.650 |
Why?
|
Female | 84 | 2022 | 375205 | 0.640 |
Why?
|
Contraception Behavior | 1 | 2019 | 169 | 0.630 |
Why?
|
Rectum | 2 | 2019 | 887 | 0.620 |
Why?
|
Condoms | 1 | 2019 | 325 | 0.610 |
Why?
|
Primary Health Care | 5 | 2022 | 4485 | 0.590 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 265 | 0.580 |
Why?
|
Mass Screening | 8 | 2022 | 5182 | 0.580 |
Why?
|
Maternal Mortality | 1 | 2017 | 280 | 0.550 |
Why?
|
Physicians | 3 | 2020 | 4292 | 0.550 |
Why?
|
Delayed Diagnosis | 4 | 2020 | 409 | 0.550 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 570 | 0.540 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2022 | 1962 | 0.540 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1055 | 0.540 |
Why?
|
Government Regulation | 1 | 2019 | 542 | 0.520 |
Why?
|
Humans | 91 | 2023 | 708843 | 0.490 |
Why?
|
Disclosure | 1 | 2019 | 732 | 0.470 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 791 | 0.470 |
Why?
|
Physical Examination | 1 | 2019 | 1245 | 0.460 |
Why?
|
Sexual Behavior | 2 | 2019 | 1879 | 0.460 |
Why?
|
Politics | 1 | 2019 | 757 | 0.450 |
Why?
|
United States | 29 | 2022 | 67165 | 0.450 |
Why?
|
Pregnancy, Unwanted | 1 | 2011 | 28 | 0.450 |
Why?
|
Teaching | 1 | 2019 | 1185 | 0.430 |
Why?
|
Insurance Claim Review | 4 | 2022 | 736 | 0.420 |
Why?
|
Insurance, Health | 4 | 2021 | 2475 | 0.420 |
Why?
|
Health Benefit Plans, Employee | 1 | 2013 | 334 | 0.410 |
Why?
|
Motivation | 1 | 2020 | 1868 | 0.400 |
Why?
|
False Positive Reactions | 3 | 2019 | 1004 | 0.400 |
Why?
|
Ultrasonography, Mammary | 3 | 2022 | 248 | 0.400 |
Why?
|
Preoperative Care | 1 | 2019 | 2357 | 0.380 |
Why?
|
Health Services Accessibility | 6 | 2022 | 4988 | 0.380 |
Why?
|
Maine | 4 | 2022 | 140 | 0.380 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2021 | 3934 | 0.360 |
Why?
|
Africa South of the Sahara | 4 | 2020 | 685 | 0.360 |
Why?
|
Massachusetts | 6 | 2022 | 8712 | 0.350 |
Why?
|
Adult | 36 | 2022 | 211041 | 0.350 |
Why?
|
Genetic Testing | 2 | 2021 | 3303 | 0.350 |
Why?
|
Rural Population | 5 | 2020 | 2130 | 0.350 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2653 | 0.350 |
Why?
|
Patient Participation | 1 | 2018 | 1447 | 0.340 |
Why?
|
BRCA2 Protein | 3 | 2022 | 690 | 0.340 |
Why?
|
Health Expenditures | 2 | 2021 | 2240 | 0.340 |
Why?
|
Drug Implants | 2 | 2019 | 241 | 0.310 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2779 | 0.310 |
Why?
|
Pregnancy | 13 | 2022 | 26832 | 0.310 |
Why?
|
Delivery of Health Care | 8 | 2022 | 4810 | 0.310 |
Why?
|
BRCA1 Protein | 3 | 2022 | 1039 | 0.300 |
Why?
|
Patient Acceptance of Health Care | 3 | 2021 | 2927 | 0.300 |
Why?
|
Decision Making | 2 | 2018 | 3802 | 0.300 |
Why?
|
Health Personnel | 1 | 2019 | 2983 | 0.290 |
Why?
|
Middle Aged | 30 | 2022 | 213752 | 0.290 |
Why?
|
Health Status Disparities | 1 | 2017 | 1711 | 0.290 |
Why?
|
Young Adult | 16 | 2022 | 55940 | 0.290 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7487 | 0.280 |
Why?
|
Developing Countries | 5 | 2021 | 2674 | 0.280 |
Why?
|
Patient Advocacy | 1 | 2007 | 350 | 0.280 |
Why?
|
Prescription Drugs | 1 | 2012 | 607 | 0.270 |
Why?
|
Adolescent | 18 | 2022 | 84718 | 0.270 |
Why?
|
Medication Adherence | 1 | 2016 | 2019 | 0.270 |
Why?
|
Papillomavirus Vaccines | 2 | 2021 | 477 | 0.270 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3690 | 0.240 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 23020 | 0.230 |
Why?
|
Retrospective Studies | 10 | 2022 | 71483 | 0.230 |
Why?
|
Biopsy | 6 | 2022 | 6766 | 0.220 |
Why?
|
Healthcare Disparities | 3 | 2022 | 2996 | 0.210 |
Why?
|
Referral and Consultation | 4 | 2019 | 3436 | 0.210 |
Why?
|
Postal Service | 1 | 2020 | 103 | 0.200 |
Why?
|
Philadelphia | 1 | 2020 | 266 | 0.190 |
Why?
|
Ultrasonography | 3 | 2020 | 5918 | 0.190 |
Why?
|
Medical Tourism | 1 | 2020 | 54 | 0.190 |
Why?
|
Birth Intervals | 1 | 2019 | 54 | 0.190 |
Why?
|
Legislation, Medical | 1 | 2019 | 100 | 0.180 |
Why?
|
Hospitals, District | 1 | 2019 | 97 | 0.170 |
Why?
|
Aged | 17 | 2022 | 161488 | 0.170 |
Why?
|
Ethiopia | 4 | 2021 | 463 | 0.170 |
Why?
|
Colonoscopy | 3 | 2019 | 1335 | 0.170 |
Why?
|
Risk Factors | 11 | 2021 | 69553 | 0.170 |
Why?
|
Women's Rights | 1 | 2017 | 55 | 0.160 |
Why?
|
Private Sector | 1 | 2020 | 390 | 0.160 |
Why?
|
Review Literature as Topic | 2 | 2021 | 316 | 0.160 |
Why?
|
Tamoxifen | 1 | 2022 | 989 | 0.160 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1740 | 0.160 |
Why?
|
Health Plan Implementation | 1 | 2020 | 356 | 0.150 |
Why?
|
China | 1 | 2022 | 2251 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2019 | 58184 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 411 | 0.140 |
Why?
|
Students, Medical | 1 | 2008 | 1740 | 0.140 |
Why?
|
Mentors | 1 | 2020 | 604 | 0.140 |
Why?
|
Health Facilities | 1 | 2019 | 450 | 0.140 |
Why?
|
Self Report | 2 | 2019 | 3397 | 0.140 |
Why?
|
Developed Countries | 1 | 2017 | 402 | 0.140 |
Why?
|
Age Factors | 5 | 2019 | 18712 | 0.130 |
Why?
|
Health Policy | 2 | 2021 | 2615 | 0.130 |
Why?
|
Time Factors | 6 | 2021 | 41038 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11126 | 0.130 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4712 | 0.130 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 414 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3515 | 0.130 |
Why?
|
Pathology, Clinical | 1 | 2017 | 368 | 0.130 |
Why?
|
Hospitals, Rural | 1 | 2015 | 152 | 0.130 |
Why?
|
Comprehension | 1 | 2019 | 601 | 0.120 |
Why?
|
Income | 3 | 2021 | 1775 | 0.120 |
Why?
|
Qualitative Research | 2 | 2019 | 2506 | 0.120 |
Why?
|
Cohort Studies | 5 | 2022 | 39292 | 0.120 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1110 | 0.110 |
Why?
|
Cervical Intraepithelial Neoplasia | 1 | 2015 | 315 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1147 | 0.110 |
Why?
|
Maternal Health Services | 2 | 2020 | 432 | 0.110 |
Why?
|
Male | 18 | 2022 | 349524 | 0.110 |
Why?
|
Withholding Treatment | 1 | 2016 | 580 | 0.110 |
Why?
|
Organizational Innovation | 1 | 2015 | 572 | 0.110 |
Why?
|
Teratogens | 1 | 2012 | 114 | 0.110 |
Why?
|
Medically Uninsured | 2 | 2020 | 862 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1047 | 0.110 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3885 | 0.110 |
Why?
|
Peru | 2 | 2022 | 835 | 0.110 |
Why?
|
Postpartum Period | 3 | 2022 | 970 | 0.110 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5235 | 0.110 |
Why?
|
New Hampshire | 2 | 2021 | 176 | 0.100 |
Why?
|
Contraceptives, Oral | 1 | 2013 | 549 | 0.100 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2013 | 342 | 0.100 |
Why?
|
Life Expectancy | 1 | 2017 | 1116 | 0.100 |
Why?
|
Premature Birth | 1 | 2022 | 1498 | 0.100 |
Why?
|
Educational Status | 2 | 2019 | 2278 | 0.100 |
Why?
|
South Carolina | 2 | 2021 | 97 | 0.100 |
Why?
|
Quality Indicators, Health Care | 1 | 2020 | 1822 | 0.100 |
Why?
|
Risk | 2 | 2019 | 9641 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2017 | 1156 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2100 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1336 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2561 | 0.090 |
Why?
|
Administration, Oral | 1 | 2016 | 3944 | 0.090 |
Why?
|
Drugs, Generic | 1 | 2013 | 479 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2806 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2765 | 0.080 |
Why?
|
Congenital Abnormalities | 1 | 2012 | 696 | 0.080 |
Why?
|
Hospitals | 2 | 2022 | 3290 | 0.080 |
Why?
|
Emigrants and Immigrants | 1 | 2013 | 475 | 0.080 |
Why?
|
Mental Health | 1 | 2020 | 2602 | 0.080 |
Why?
|
Life Style | 1 | 2018 | 3636 | 0.080 |
Why?
|
Survivors | 1 | 2017 | 2149 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 20172 | 0.080 |
Why?
|
Minority Groups | 1 | 2013 | 1077 | 0.070 |
Why?
|
Registries | 1 | 2022 | 7989 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 34151 | 0.070 |
Why?
|
Colorectal Neoplasms | 3 | 2019 | 6497 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1223 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2579 | 0.070 |
Why?
|
Models, Statistical | 2 | 2019 | 5034 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3316 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2219 | 0.060 |
Why?
|
Residence Characteristics | 1 | 2013 | 1969 | 0.060 |
Why?
|
Sex Factors | 1 | 2017 | 10566 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5348 | 0.060 |
Why?
|
Colonography, Computed Tomographic | 1 | 2004 | 177 | 0.060 |
Why?
|
Clinical Competence | 1 | 2018 | 4615 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39038 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2017 | 4266 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 7763 | 0.050 |
Why?
|
Africa, Eastern | 1 | 2020 | 71 | 0.050 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2001 | 192 | 0.050 |
Why?
|
Incidence | 2 | 2016 | 20320 | 0.050 |
Why?
|
Jews | 1 | 2021 | 365 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2021 | 179 | 0.050 |
Why?
|
Prospective Studies | 2 | 2021 | 50597 | 0.050 |
Why?
|
Chemoprevention | 1 | 2022 | 313 | 0.050 |
Why?
|
Linear Models | 2 | 2021 | 5986 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 7644 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 504 | 0.040 |
Why?
|
Policy | 1 | 2021 | 359 | 0.040 |
Why?
|
Aromatase Inhibitors | 1 | 2022 | 503 | 0.040 |
Why?
|
Indians, North American | 1 | 2021 | 363 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 9488 | 0.040 |
Why?
|
Patients | 1 | 2023 | 738 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 759 | 0.040 |
Why?
|
Asian Americans | 1 | 2021 | 699 | 0.040 |
Why?
|
Propensity Score | 1 | 2023 | 1715 | 0.040 |
Why?
|
Pregnant Women | 1 | 2020 | 479 | 0.040 |
Why?
|
Aftercare | 1 | 2021 | 689 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2019 | 351 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1513 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1652 | 0.030 |
Why?
|
Workplace | 1 | 2020 | 852 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2020 | 1124 | 0.030 |
Why?
|
Sexually Transmitted Diseases | 1 | 2018 | 558 | 0.030 |
Why?
|
San Francisco | 1 | 2013 | 157 | 0.030 |
Why?
|
Counseling | 1 | 2021 | 1504 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1596 | 0.030 |
Why?
|
Health Resources | 1 | 2019 | 922 | 0.030 |
Why?
|
Consensus | 1 | 2020 | 2713 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2001 | 2708 | 0.020 |
Why?
|
National Health Programs | 1 | 2013 | 438 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2557 | 0.020 |
Why?
|
Telephone | 1 | 2013 | 624 | 0.020 |
Why?
|
Caregivers | 1 | 2020 | 1906 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 2864 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3074 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3329 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23284 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 28919 | 0.020 |
Why?
|
Medical Oncology | 1 | 2019 | 2098 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3693 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2920 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4015 | 0.020 |
Why?
|
African Americans | 1 | 2021 | 5118 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13274 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2020 | 4176 | 0.020 |
Why?
|
Medicare | 1 | 2019 | 5691 | 0.010 |
Why?
|
Health Surveys | 1 | 2013 | 3994 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 24433 | 0.010 |
Why?
|
Child | 2 | 2021 | 73636 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12447 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 7089 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13468 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17218 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2016 | 4173 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 14712 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29262 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2001 | 2028 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 61932 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2001 | 3418 | 0.000 |
Why?
|